SHPH.F Stock Overview
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Sihuan Pharmaceutical Holdings Group Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.045 |
52 Week High | HK$0.12 |
52 Week Low | HK$0.045 |
Beta | 0.70 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | -52.63% |
3 Year Change | n/a |
5 Year Change | -82.35% |
Change since IPO | -87.84% |
Recent News & Updates
Recent updates
Shareholder Returns
SHPH.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 2.2% | 0.2% |
1Y | -52.6% | 25.5% | 28.1% |
Return vs Industry: SHPH.F underperformed the US Pharmaceuticals industry which returned 25.8% over the past year.
Return vs Market: SHPH.F underperformed the US Market which returned 28.8% over the past year.
Price Volatility
SHPH.F volatility | |
---|---|
SHPH.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SHPH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHPH.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 3,241 | Weicheng Guo | https://www.sihuanpharm.com |
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing.
Sihuan Pharmaceutical Holdings Group Ltd. Fundamentals Summary
SHPH.F fundamental statistics | |
---|---|
Market cap | US$679.66m |
Earnings (TTM) | -US$282.47m |
Revenue (TTM) | US$245.31m |
2.6x
P/S Ratio-2.2x
P/E RatioIs SHPH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHPH.F income statement (TTM) | |
---|---|
Revenue | CN¥1.77b |
Cost of Revenue | CN¥541.07m |
Gross Profit | CN¥1.23b |
Other Expenses | CN¥3.27b |
Earnings | -CN¥2.04b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.22 |
Gross Margin | 69.48% |
Net Profit Margin | -115.15% |
Debt/Equity Ratio | 24.3% |
How did SHPH.F perform over the long term?
See historical performance and comparison